Table 1 Detailed morphology of renal cell carcinoma cases submitted for TFE3 and/or TFEB FISH
TFE3 translocation (n=21) | TFEB translocation (n=4) | TFEB amplification (n=6) | No detected MITF aberration (n=54) | |
---|---|---|---|---|
Predominant nested architecture | 7/21 (33%) | 2/4 (50%) | 2/6 (33%) | 13/54 (24%) |
Predominant papillary architecture | 8/21 (38%) | 2/4 (50%) | 4/6 (67%) | 21/54 (39%) |
Predominant pseudopapillary architecture | 4/21 (19%) | 0/4 (0%) | 0/6 (0%) | 17/54 (32%) |
Predominant solid architecture | 0/20 (0%) | 0/4 (0%) | 0/6 (0%) | 2/54 (4%) |
Predominant cystic architecture | 1/21 (5%) | 0/4 (0%) | 0/6 (0%) | 0/54 (0%) |
Predominant trabecular architecture | 0/20 (0%) | 0/4 (0%) | 0/6 (0%) | 1/54 (2%) |
Predominant tubular architecture | 1/21 (5%) | 0/4 (0%) | 0/6 (0%) | 0/54 (0%) |
Entrapped benign renal tubules | 4/20 (20%) | 4/4 (100%) | 3/6 (50%) | 16/52 (31%) |
Dual (eosinophilic and clear) cytoplasmic tones | 16/21 (76%) | 4/4 (100%) | 5/6 (83%) | 31/54 (57%) |
Biphasic TFEB t-RCC-like | 4/21 (19%) | 2/4 (50%) | 0/6 (0%)a | 0/54 (0%) |
Subnuclear clearing and linear nuclear array | 7/21 (33%) | 0/4 (0%) | 0/6 (0%)b | 4/54 (7%) |
Oncocytic features | 5/21 (24%) | 0/4 (0%) | 4/6 (67%) | 22/54 (41%) |
Voluminous clear and/or eosinophilic cytoplasm | 19/21 (91%) | 3/4 (75%) | 4/6 (67%) | 37/54 (69%) |
Psammomatous calcifications | 14/21 (67%) | 4/4 (100%) | 1/6 (17%) | 14/54 (26%) |
Foamy histiocytes | 4/21 (19%) | 0/4 (0%) | 3/6 (50%) | 22/54 (41%) |
Necrosis | 9/21 (43%) | 1/4 (25%) | 4/6 (67%) | 26/54 (48%) |
Sarcomatoid differentiation | 2/21 (10%) | 0/4 (0%) | 1/6 (17%) | 5/54 (9%) |
Nuclear pseudoinclusions | 12/21 (57%)c | 1/4 (25%) | 3/6 (50%)c | 9/54 (17%)c |
Cytoplasmic vacuolization | 19/21 (91%) | 4/4 (100%) | 6/6 (100%) | 47/54 (87%) |